Patents by Inventor Huw Alun Davies

Huw Alun Davies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF DETECTING A FRAGMENT OF NEUROSECRETORY PROTEIN VGF FOR DIAGNOSING ALZHEIMER'S DISEASE
    Publication number: 20110294865
    Abstract: The present invention provides a neurosecretory protein VGF peptide useful in qualifying Alzheimer's disease status in a patient. In particular, this peptide and modified forms thereof may be used to classify a subject sample as Alzheimer's disease or non-Alzheimer's disease. The peptide biomarker can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: July 2, 2010
    Publication date: December 1, 2011
    Applicant: VERMILLION, INC.
    Inventors: Huw Alun Davies, Kaj Blennow, James McGuire, Valdimir Podust, Anja Hviid Simonsen
  • Saposin D and FAM3C are biomarkers for alzheimer's disease
    Patent number: 7993868
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Alzheimer's disease status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as Alzheimer's disease or non-Alzheimer's disease. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Grant
    Filed: April 11, 2006
    Date of Patent: August 9, 2011
    Assignee: Vermillion, Inc.
    Inventors: Huw Alun Davies, Kaj Blennow, James Norton McGuire, Vladimir N. Podust, Anja Hviid Simonsen
  • BIOMARKERS FOR ALZHEIMER'S DISEASE
    Publication number: 20110129920
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Alzheimer's disease status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as Alzheimer's or non-Alzheimer's dementia or normal. The biomarkers can be detected by SELDI mass spectrometry. In addition, the invention provides appropriate treatment interventions and methods for measuring response to treatment. Certain biomarkers of the invention may also be suitable for employment as radio-labeled ligands in non-invasive imaging techniques such as Positron Emission Tomography (PET).
    Type: Application
    Filed: July 28, 2010
    Publication date: June 2, 2011
    Applicant: Vermillion, Inc.
    Inventors: Huw Alun Davies, James McGuire, Anja Hviid Simonsen, Kaj Blennow, Vladimir Podust
  • Biomarkers for alzheimer's disease
    Patent number: 7794948
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Alzheimer's disease status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as Alzheimer's or non-Alzheimer's dementia or normal. The biomarkers can be detected by SELDI mass spectrometry. In addition, the invention provides appropriate treatment interventions and methods for measuring response to treatment. Certain biomarkers of the invention may also be suitable for employment as radio-labeled ligands in non-invasive imaging techniques such as Positron Emission Tomography (PET).
    Type: Grant
    Filed: November 6, 2004
    Date of Patent: September 14, 2010
    Assignee: Vermilllion, Inc.
    Inventors: Huw Alun Davies, James McGuire, Anja Hviid Simonsen, Kaj Blennow, Vladimir Podust
  • Methods of detecting a fragment of neurosecretory protein VGF for diagnosing alzheimer's disease
    Patent number: 7749716
    Abstract: The present invention provides a neurosecretory protein VGF peptide useful in qualifying Alzheimer's disease status in a patient. In particular, this peptide and modified forms thereof may be used to classify a subject sample as Alzheimer's disease or non-Alzheimer's disease. The peptide biomarker can be detected by SELDI mass spectrometry.
    Type: Grant
    Filed: June 13, 2006
    Date of Patent: July 6, 2010
    Assignee: Vermilllion, Inc.
    Inventors: Huw Alun Davies, Kaj Blennow, James McGuire, Vladimir Podust, Anja Hviid Simonsen
  • SAPOSIN D AND FAM3C ARE BIOMARKERS FOR ALZHEIMER'S DISEASE
    Publication number: 20090226897
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Alzheimer's disease status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as Alzheimer's disease or non-Alzheimer's disease. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: April 11, 2006
    Publication date: September 10, 2009
    Applicant: Vermillion, Inc
    Inventors: Huw Alun Davies, Kaj Blennow, James Norton McGuire, Vladimir N. Podust, Anja Hviid Simonsen